S'abonner

Anaphylaxis in America: A national physician survey - 05/03/15

Doi : 10.1016/j.jaci.2014.10.049 
Ashley M. Altman, DO a, Carlos A. Camargo, MD, DrPH b, F. Estelle R. Simons, MD c, Philip Lieberman, MD d, Hugh A. Sampson, MD e, Lawrence B. Schwartz, MD, PhD f, F. Myron Zitt, MD g, Charlotte Collins, JD h, Michael Tringale, MSM h, Marilyn Wilkinson, ScD i, Robert A. Wood, MD a
a Department of Pediatrics, Division of Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Md 
b Departments of Medicine and Epidemiology, Massachusetts General Hospital, Boston, Mass 
c Department of Pediatrics and Child Health, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg, Manitoba, Canada 
d Departments of Internal Medicine and Pediatrics, University of Tennessee College of Medicine, Germantown, Tenn 
e Department of Pediatrics, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY 
f Department of Medicine, Division of Rheumatology, Allergy & Immunology, Virginia Commonwealth University, Richmond, Va 
g Department of Medicine, State University of NY Stony Brook, Stony Brook, NY 
h Asthma and Allergy Foundation of America, Landover, Md 
i Abt SRBI, Inc, Silver Spring, Md 


 The Asthma and Allergy Foundation of America supported this study.
 Disclosure of potential conflict of interest: A. M. Altman has received research support from the National Institutes of Health (NIH) and is employed by the Johns Hopkins University School of Medicine. C. A. Camargo has received consultancy fees from the Asthma and Allergy Foundation of America, Dey/Mylan, and Sanofi-Aventis and has received research support from Sanofi-Aventis. F. E. R. Simons is a board member for the Sanofi Canada Medical Advisory Board. P. Lieberman has received research support from Meda, Sanofi, Mylan, AstraZeneca, Genentech, and Novartis. H. A. Sampson has received research support from the National Institute of Allergy and Infectious Diseases/NIH and the Food Allergy Research and Education; is Chair of the PhARF Award review committee; has received consultancy fees from Allertein Therapeutics, Regeneron, and Danone Research Institute; and has received lecture fees from ThermoFisher Scientific, UCB, and Pfizer. L. B. Schwartz has received consultancy fees from Sanofi, Viropharma, and Genentech; has received research support from GlaxoSmithKline, NeilMed, Merck, CSL Behring, and Dyax; and has received royalties from ThermoFisher, Hycult & BioLegend, Millipore & Santa Cruz, Elsevier, and UpToDate. F. M. Zitt has received lecture fees from Integrity/Mylan and Sanofi and has received payment for the development of educational presentations from Integrity. C. Collins has received research support from Sanofi-Aventis and Pfizer and has received travel support from Mylan Specialty, LLP. M. Tringale has received research support from Sanofi-Aventis. R. A. Wood has received consultancy fees from the Asthma and Allergy Foundation of America, is employed by Johns Hopkins University, has received research support from the NIH, and has received royalties from UpToDate. M. Wilkinson declares that she has no relevant conflicts of interest.


© 2014  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 135 - N° 3

P. 830-833 - mars 2015 Retour au numéro
Article précédent Article précédent
  • Claudin-1 polymorphism modifies the effect of mold exposure on the development of atopic dermatitis and production of IgE
  • Ho-Sung Yu, Mi-Jin Kang, Ji-Won Kwon, So-Yeon Lee, Eun Lee, Song-I. Yang, Young-Ho Jung, Kyungmo Hong, Young-Joon Kim, Seung-Hwa Lee, Ha-Jung Kim, Hyung Young Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, Soo-Jong Hong
| Article suivant Article suivant
  • Increasing rate of hospitalizations for food-induced anaphylaxis in Italian children: An analysis of the Italian Ministry of Health database
  • Rita Nocerino, Ludovica Leone, Linda Cosenza, Roberto Berni Canani

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.